• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KIAA1429通过介导BTG2的m6A修饰在宫颈癌上皮-间质转化中的调控作用

The regulatory role of KIAA1429 in epithelial-mesenchymal transition in cervical cancer via mediating m6A modification of BTG2.

作者信息

Wang Mingyang, Wang Zhiliang, Zou Xiaofeng, Yang Danhe, Xu Ke

机构信息

Department of Gynecology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003 Guizhou China.

出版信息

Cytotechnology. 2025 Feb;77(1):34. doi: 10.1007/s10616-024-00694-3. Epub 2025 Jan 3.

DOI:10.1007/s10616-024-00694-3
PMID:39760059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11699186/
Abstract

UNLABELLED

Cervical cancer (CC) represents one of the important cancers affecting global female population worldwide. We sought to elucidate the roles and mechanisms of KIAA1429 in the malignant properties of CC cells and the epithelial-mesenchymal transition (EMT) process. KIAA1429 was predicted to be abnormally expressed in CC and correlate with shortened survival of CC patients by GEPIA2 and GSCA databases. High expression of KIAA1429 in human CC cell lines (SiHa, HT-3) was validated by RT-qPCR and Western blot assays. A series of small interfering (si)RNAs including si-KIAA1429-1, si-KIAA1429-2, si-YTHDF2, si-BTG2, and si-negative control (NC) were utilized to interfere the expression levels of KIAA1429, YTHDF2, and BTG2, respectively. Consequently, KIAA1429 silencing attenuated the proliferation, migratory, and invasive functions of CC cells and repressed EMT while promoting CC cell apoptosis. Mechanistically, KIAA1429 could affect N6-methyladenosine (m6A) modification to attenuate the stability of BTG2 mRNA and down-regulate its expression. Additionally, loss of BTG2 partly counteracted the effects of si-KIAA1429 on repressing the malignant activities of CC cells. The aforementioned results collectively demonstrated that KIAA1429-mediated m6A modification of BTG2 and contributed to malignant progression of CC in vitro.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s10616-024-00694-3.

摘要

未标记

宫颈癌(CC)是影响全球女性人口的重要癌症之一。我们试图阐明KIAA1429在CC细胞恶性特性和上皮-间质转化(EMT)过程中的作用及机制。通过GEPIA2和GSCA数据库预测,KIAA1429在CC中异常表达,并与CC患者生存期缩短相关。通过RT-qPCR和蛋白质免疫印迹分析验证了KIAA1429在人CC细胞系(SiHa、HT-3)中的高表达。分别使用一系列小干扰(si)RNA,包括si-KIAA1429-1、si-KIAA1429-2、si-YTHDF2、si-BTG2和si阴性对照(NC)来干扰KIAA1429、YTHDF2和BTG2的表达水平。因此,沉默KIAA1429可减弱CC细胞的增殖、迁移和侵袭功能,抑制EMT,同时促进CC细胞凋亡。机制上,KIAA1429可影响N6-甲基腺苷(m6A)修饰,以减弱BTG2 mRNA的稳定性并下调其表达。此外,BTG2的缺失部分抵消了si-KIAA1429对抑制CC细胞恶性活性的影响。上述结果共同表明,KIAA1429介导的BTG2的m6A修饰促进了CC的体外恶性进展。

补充信息

在线版本包含可在10.1007/s10616-024-00694-3获取的补充材料。

相似文献

1
The regulatory role of KIAA1429 in epithelial-mesenchymal transition in cervical cancer via mediating m6A modification of BTG2.KIAA1429通过介导BTG2的m6A修饰在宫颈癌上皮-间质转化中的调控作用
Cytotechnology. 2025 Feb;77(1):34. doi: 10.1007/s10616-024-00694-3. Epub 2025 Jan 3.
2
The methyltransferase KIAA1429 potentiates cervical cancer tumorigenesis via modulating LARP1 mRNA m6A modification and stability.甲基转移酶KIAA1429通过调节LARP1 mRNA的m6A修饰和稳定性增强宫颈癌的肿瘤发生。
Histol Histopathol. 2024 Nov 4:18843. doi: 10.14670/HH-18-843.
3
KIAA1429 promotes the malignancy of oral squamous cell carcinoma by regulating CA9 m6A methylation.KIAA1429通过调控CA9的m6A甲基化促进口腔鳞状细胞癌的恶性发展。
Cytotechnology. 2024 Oct;76(5):585-594. doi: 10.1007/s10616-024-00640-3. Epub 2024 Jul 9.
4
KIAA1429 and AlkB Homolog 5 Regulate Bladder Cancer Progression via N-Methyladenosine-Dependent Modulation of Sonic Hedgehog Signaling.KIAA1429和AlkB同源物5通过N-甲基腺苷依赖性调节音猬因子信号通路调控膀胱癌进展。
Mol Carcinog. 2025 Jun 26. doi: 10.1002/mc.70004.
5
Hypoxia-Inducible Factor HIF1α Regulates the Expression of SLC7A1 to Mediate Erastin-Induced Ferroptosis in Cervical Cancer Cells.缺氧诱导因子HIF1α调节SLC7A1的表达以介导厄拉司丁诱导的宫颈癌细胞铁死亡。
J Gene Med. 2025 Jul;27(7):e70027. doi: 10.1002/jgm.70027.
6
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.基因扩增驱动的 RNA 甲基转移酶 KIAA1429 通过 m6A-YTHDF2 依赖途径调节 BTG2 促进肺腺癌的发生。
Cancer Commun (Lond). 2022 Jul;42(7):609-626. doi: 10.1002/cac2.12325. Epub 2022 Jun 21.
7
circ-NOLC1 inhibits the development of cervical cancer by regulating miR-330-5p-PALM signaling axis.环状非编码RNA NOLC1通过调控miR-330-5p-PALM信号轴抑制宫颈癌的发展。
Hereditas. 2025 Jun 18;162(1):108. doi: 10.1186/s41065-025-00478-5.
8
METTL3 regulates Ambra1 expression in an m6A-YTHDF2-dependent manner to promote mantle cell lymphoma progression.METTL3以m6A - YTHDF2依赖的方式调节Ambra1表达,以促进套细胞淋巴瘤进展。
J Transl Med. 2025 Jul 1;23(1):703. doi: 10.1186/s12967-025-06647-4.
9
Mechanism of the N6-methyladenosine reader heterogeneous nuclear ribonucleoprotein C facilitating immune escape in thyroid cancer by stabilizing programmed death ligand 1.N6-甲基腺苷阅读器异质核糖核蛋白C通过稳定程序性死亡配体1促进甲状腺癌免疫逃逸的机制
Cytotechnology. 2025 Jun;77(3):96. doi: 10.1007/s10616-025-00755-1. Epub 2025 May 6.
10
Dual functions of the ΔNp63-miR-141-3p-YAP1 regulatory axis in cervical cancer progression are dependent on histological subtype.ΔNp63-miR-141-3p-YAP1调控轴在宫颈癌进展中的双重功能取决于组织学亚型。
Sci Rep. 2025 Jul 2;15(1):23155. doi: 10.1038/s41598-025-07237-6.

引用本文的文献

1
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.VIRMA(甲基转移酶复合物的核心成分)在癌症及癌症治疗中的多方面作用
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
2
N6-methyladenosine in cervical carcinogenesis: Mechanistic insights and therapeutic perspectives (Review).N6-甲基腺苷在宫颈癌发生中的作用机制及治疗前景(综述)
Oncol Lett. 2025 Jul 14;30(3):442. doi: 10.3892/ol.2025.15188. eCollection 2025 Sep.

本文引用的文献

1
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an mA-YTHDF2-dependent manner.KIAA1429 通过依赖于 mA-YTHDF2 的方式来破坏 RASD1 mRNA 的稳定性,从而促进胃癌的进展。
J Transl Med. 2024 Jun 20;22(1):584. doi: 10.1186/s12967-024-05375-5.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
A granularity-level information fusion strategy on hypergraph transformer for predicting synergistic effects of anticancer drugs.基于超图Transformer 的粒度级信息融合策略预测抗癌药物协同作用
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad522.
4
Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.癌症进展中的上皮-间充质转化:揭开驱动治疗抵抗的免疫抑制模块。
Cancer Metastasis Rev. 2024 Mar;43(1):155-173. doi: 10.1007/s10555-023-10141-y. Epub 2023 Sep 30.
5
Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy.泛癌症分析和实验验证揭示了 m6A 甲基转移酶 KIAA1429 作为一种潜在的诊断、预后和免疫治疗的生物标志物。
Aging (Albany NY). 2023 Aug 21;15(17):8664-8691. doi: 10.18632/aging.204968.
6
BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.BTG2 抑制宫颈鳞癌细胞的生长和转移。
Pathol Res Pract. 2023 Jul;247:154577. doi: 10.1016/j.prp.2023.154577. Epub 2023 May 26.
7
KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.KIAA1429 介导的 CHST11 的 m6A 修饰通过调节 Hippo-YAP 通路促进弥漫性大 B 细胞淋巴瘤的进展。
Cell Mol Biol Lett. 2023 Apr 19;28(1):32. doi: 10.1186/s11658-023-00445-w.
8
Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006-2030: A Bayesian Age-Period-Cohort Modeling Study.中国宫颈癌发病率和死亡率趋势预测:基于贝叶斯年龄-时期-队列模型研究。
Cancer Epidemiol Biomarkers Prev. 2023 Jun 1;32(6):825-833. doi: 10.1158/1055-9965.EPI-22-0674.
9
GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels.GSCA:一个用于在基因组、药物基因组学和免疫基因组学水平进行基因集癌症分析的综合平台。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac558.
10
KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification.KIAA1429 通过 m6A 甲基化修饰介导索拉非尼耐药肝癌中的上皮间质转化。
Cancer Med. 2023 Mar;12(6):7222-7233. doi: 10.1002/cam4.5432. Epub 2022 Nov 24.